MOLN
Molecular Partners AG ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$142.67M
P/E Ratio
—
EPS
$-1.98
Beta
0.74
52W High
$5.36
52W Low
$3.41
50-Day MA
$4.31
200-Day MA
$4.13
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.70
PEG Ratio
—
About Molecular Partners AG ADR
Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-39.14M |
| EBITDA | $-54.54M |
| Operating Margin | 0.00% |
| Return on Equity | -55.50% |
| Return on Assets | -26.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.76 |
| Price-to-Book | 1.49 |
| Price-to-Sales (TTM) | 156.56 |
| EV/Revenue | 3.814 |
| EV/EBITDA | 1.24 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $37.51M |
| Float | $19.82M |
| % Insiders | 0.00% |
| % Institutions | 9.60% |
Historical Volatility
HV 10-Day
41.65%
HV 20-Day
44.01%
HV 30-Day
51.69%
HV 60-Day
51.24%
HV Rank
34.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($11.09 target)
4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/16/2026